The human ether-à-go-go related gene (hERG) inhibition at 1uM of a drug with the SMILES NC(=O)CC[C@@H]1NC(=O)[C@H](CO)NC(=O)c2cc([N+](=O)[O-])cc(I)c2NCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O is 13.528\%.
The {herg_central_at_1uM__names__noun} of a {#drug|compound!} with the {SMILES__description} {SMILES#} is {herg_central_at_1uM#}{herg_central_at_1uM__units}.
NC(=O)CC[C@@H]1NC(=O)[C@H](CO)NC(=O)c2cc([N+](=O)[O-])cc(I)c2NCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
NC(=O)CC[C@@H]1NC(=O)[C@H](CO)NC(=O)c2cc([N+](=O)[O-])cc(I)c2NCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
(5S,8S,11S,14S)-11-(3-amino-3-oxopropyl)-14-(hydroxymethyl)-8-[(4-hydroxyphenyl)methyl]-21-iodo-19-nitro-7,10,13,16-tetraoxo-2,6,9,12,15-pentazabicyclo[15.4.0]henicosa-1(17),18,20-triene-5-carboxamide